Unknown

Dataset Information

0

Affibody-Binding Ligands.


ABSTRACT: While antibodies remain established therapeutic and diagnostic tools, other protein scaffolds are emerging as effective and safer alternatives. Affibodies in particular are a new class of small proteins marketed as bio-analytic reagents. They feature tailorable binding affinity, low immunogenicity, high tissue permeation, and high expression titer in bacterial hosts. This work presents the development of affibody-binding peptides to be utilized as ligands for their purification from bacterial lysates. Affibody-binding candidates were identified by screening a peptide library simultaneously against two model affibodies (anti-immunoglobulin G (IgG) and anti-albumin) with the aim of selecting peptides targeting the conserved domain of affibodies. An ensemble of homologous sequences identified from screening was synthesized on Toyopearl® resin and evaluated via binding studies to select sequences that afford high product binding and recovery. The affibody-peptide interaction was also evaluated by in silico docking, which corroborated the targeting of the conserved domain. Ligand IGKQRI was validated through purification of an anti-ErbB2 affibody from an Escherichia coli lysate. The values of binding capacity (~5 mg affibody per mL of resin), affinity (KD ~1 ?M), recovery and purity (64-71% and 86-91%), and resin lifetime (100 cycles) demonstrate that IGKQRI can be employed as ligand in affibody purification processes.

SUBMITTER: Barozzi A 

PROVIDER: S-EPMC7312911 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Affibody-Binding Ligands.

Barozzi Annalisa A   Lavoie R Ashton RA   Day Kevin N KN   Prodromou Raphael R   Menegatti Stefano S  

International journal of molecular sciences 20200527 11


While antibodies remain established therapeutic and diagnostic tools, other protein scaffolds are emerging as effective and safer alternatives. Affibodies in particular are a new class of small proteins marketed as bio-analytic reagents. They feature tailorable binding affinity, low immunogenicity, high tissue permeation, and high expression titer in bacterial hosts. This work presents the development of affibody-binding peptides to be utilized as ligands for their purification from bacterial ly  ...[more]

Similar Datasets

| S-EPMC10489752 | biostudies-literature
| S-EPMC4884024 | biostudies-literature
| S-EPMC5865129 | biostudies-literature
| S-EPMC7215652 | biostudies-literature
| S-EPMC4070320 | biostudies-literature
| S-EPMC5382565 | biostudies-literature
| S-EPMC5322329 | biostudies-literature
| S-EPMC7085990 | biostudies-literature
| S-EPMC4268634 | biostudies-literature
| S-EPMC2832595 | biostudies-literature